Skip to main content

Field Safety Notice Terumo RelayPlus, RelayPro and TREO-Stent Graft Systems (ICN 3542)

Important Customer Notice Status New Type Product Recall

Ref: 2026/3542 ICN Number: 3542

NHSSC: 83

Alert:

  • Terumo has issued a Field Safety Notice to inform consignees that Bolton Medical Inc., operating as Terumo Aortic, is conducting a voluntary medical device recall (removal) of all RelayPlus, RelayPro and TREO-Stent Graft Systems within expiry due to potential endotoxins present on the delivery system.
  • Terumo advises that an internal review identified elevated endotoxin levels on the delivery systems. Current testing indicated that approximately ~1% of the units may contain endotoxin levels above the specification.
  • Endotoxin is a pyrogen that can create reactions ranging from fever to, in rare cases, potentially life-threatening complications, including sepsis, septic shock, organ failure, and death.
  • Terumo advises that since 2023, 26 complaints have been received related to fever, infection, inflammation, and sepsis. Four of these complaints included the outcome of death. This represents a rate of 0.07%.
  • As the aetiology of an infection or inflammatory response may be related to circumstances unrelated to the procedure or device, the root cause of the complaints has not necessarily been linked to this issue although a relationship cannot be ruled out at this time.

Products Affected:

  • All within expiry date products in the ranges listed are affected.
  • Approximately 700 of the affected products are available via NHS Supply Chain’s eDirect route.
  • See our Downloads section to access the product listing for further information on the affected product codes.
  • Please note that these products are supplied on a consignment stock basis. As a result, affected
  • devices may already have been implanted, and hospitals may not hold owned stock.
  • This recall may impact future supplies. Terumo is currently unable to provide an expected recovery date but is working closely with the relevant clinicians on a case-by-case basis.

Corrective Action:

  • Bolton Medical is currently conducting a thorough root cause investigation to determine the source of the elevated endotoxins levels.
  • A potential root cause has already been identified at a supplier and corrective action has already been implemented.
  • Additional corrective actions will be implemented following completion of the full root cause investigation to eliminate all potential sources of endotoxin.

Next Steps:

  • Terumo has confirmed that it has already contacted all affected customers.
  • Terumo would like to reassure customers that patient safety and product quality remain one of its highest priorities and that it remains committed to providing high-quality products.
  • If you have additional questions, please contact your Terumo Aortic representative or email Terumo at Market_Actions-TMC@terumomedical.com.
  • Where potential alternatives are identified, customers are advised to consult their own clinical experts to ensure suitability for their organisation’s use of these products.

If you have any further questions, please contact your local NHS Supply Chain Customer Service Advisor or the Acute team.

Please be aware that in the event of a Field Safety Notice/Product Recall, we may need to provide manufacturers, UK Responsible Persons, and Distributors with customer details of customers who have potentially received the affected stock. This is to help them to reconcile their stock and evidence to the regulators that all actions have been taken to ensure that the unused products have been removed from customers to prevent inadvertent use of faulty and potentially unsafe products.

Download our publications ▼

  • 3542 Terumo Field Safety Notice 19 November 2026

    A PDF showing the Field Safety Notice for ICN 3542.
  • 3542 Terumo Product Listing 19 November 2026

    An Excel file showing the product listing for ICN 3542.